- IDH1/2 mutation and MGMT promoter methylation - The relevant survival predictors in Czech patients with brain Gliomas2016 | First Faculty of Medicine, Central Library of Charles University
- DNA methylation and hydroxymethylation patterns in acute myeloid leukemia patients with mutations in DNMT3A and IDH1/2 and their combinations2019 | Central Library of Charles University
- Current View on Management of Central Nervous System Low-grade Gliomas2016 | Faculty of Medicine in Pilsen
- New Treatment Paradigm for Patients with Anaplastic Oligodendroglial Tumors2014 | Faculty of Medicine in Pilsen
- Genetic and Epigenetic Factors Affecting Development and Prognosis of Brain Gliomas - a Review of Current Knowledge2016 | First Faculty of Medicine, Faculty of Science, Central Library of Charles University
- IDH1 and IDH2 mutations in patients with acute myeloid leukemia: Suitable targets for minimal residual disease monitoring?2018 | Faculty of Medicine in Hradec Králové
- Update on the 2016 WHO classification of tumors of the central nervous systém Part 1: Diffusely infiltrating gliomas2017 | Faculty of Medicine in Pilsen, Second Faculty of Medicine
- Periosteal osteosarcoma - personal experience with five cases2015 | Faculty of Medicine in Pilsen, Second Faculty of Medicine
- Reductive carboxylation and 2-hydroxyglutarate formation by wild-type IDH2 in breast carcinoma cells2015 | Faculty of Physical Education and Sport, First Faculty of Medicine